Home > Healthcare > Medical Devices > Diagnostic Devices > Bleeding Disorder Testing Market

Bleeding Disorder Testing Market Size

  • Report ID: GMI5623
  • Published Date: May 2023
  • Report Format: PDF

Bleeding Disorder Testing Market Size

Bleeding Disorder Testing Market size was valued at around USD 88 million in 2022 and is projected to register around 7% CAGR between 2023 and 2032. Increasing prevalence of hemophilia along with other bleeding disorders across the globe will fuel the market growth.

 

The bleeding disorder testing has improved substantially over the recent years, pertaining to the emergence of novel & accurate diagnostics. Also, in order to promote awareness regarding this disorder & associated diagnosis, several federal agencies & public associations are coming forward to increase awareness. Moreover, in recent years, awareness associated with the significance of early-stage diagnosis of bleeding disorders and its potential benefit is rising significantly in the European countries, thereby accelerating the demand for bleeding disorder testing.

 

Bleeding disorder testing involves various laboratory tests & procedures that assists in diagnosing and monitor bleeding disorders. These testing kits and analyzing instruments are extensively used in the diagnosis of bleeding disorders that include hemophilia, von Willebrand disease, idiopathic thrombocytopenic purpura, and platelet function disorders among others. These tests help identify the underlying cause of abnormal bleeding or bruising, evaluate the severity of the disorder, and offer guidance for appropriate treatment.

 

However, the lack of skilled professionals for bleeding disorder testing may adversely affect the market growth. The bleeding disorder testing techniques mandate precise operational skills for accurate diagnosis to assess optimal treatment. Thus, the lack of skilled professionals in emerging economies with poor healthcare infrastructure & medical resources might hamper the disease testing rate, thereby negatively influencing the market revenue growth. As the testing includes various steps such as sample isolation, collection, and analysis that requires precision at every step to avoid false results, it further increases the requirement for a highly educated and knowledgeable workforce. Therefore, limited skilled professionals for bleeding disorder testing might impede the industry growth to a certain extent.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Bleeding disorder testing industry size reached USD 88.3 million in 2022 and is slated to record 7% CAGR from 2023-2032 due to the increasing number of R&D activities.

Bleeding disorder testing industry share from diagnostic laboratories recorded USD 38 million in 2022 and will significantly expand with the higher availability of specialized and efficient diagnoses.

Demand for bleeding disorder testing in the U.S. will reach more than USD 54 million by 2032 due to the surging awareness regarding technologically novel products in the region.

Siemens Healthineers, F Hoffmann La Roche AG, Bio-Rad Laboratories, Thermo Fischer Scientific Inc, Cephied (Danaher Corporation), and Abbott Laboratories Inc. are some of the renowned bleeding disorder testing industry players

Bleeding Disorder Testing Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 18
  • Tables & Figures: 369
  • Countries covered: 30
  • Pages: 200
 Download Free Sample